WHODrug: A Global, Validated and Updated Dictionary for Medicinal Information

Author:

Lagerlund OlofORCID,Strese Sara,Fladvad Malin,Lindquist Marie

Abstract

AbstractThe WHODrug medicinal information dictionary is a worldwide source of global medicinal information with the aim to facilitate the coding of medications in clinical trials as well as identification of medication-related problems when monitoring patient safety, thereby supporting the development and usage of effective and safe medications. WHODrug contains individual trade names, active ingredients and additional information such as marketing authorisation holder, country of sale, pharmaceutical form and strength. All related medications are linked using a structured WHODrug alphanumeric code, connecting trade names and variation of the ingredient with the active moiety of the ingredient. Medications in WHODrug are classified using the ATC system and clustered into Standardised Drug Groupings, to allow for grouping of medications with one or more properties in common. The built-in data structure and the classification of medications in WHODrug facilitate various ways of aggregating medications for identification and analysis of possible adverse drug reactions. The different information levels in WHODrug are used to explore the relationship between a medication or a class of medications and an adverse event. By using WHODrug in clinical trials and post-marketing safety, accurate and standardised medication information can be achieved globally and allow easy information exchange. To meet the demands of WHODrug users from the pharmaceutical industry, academia and regulatory authorities, it is relevant to keep the dictionary comprehensive, validated and constantly updated on a global scale.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference22 articles.

1. Babre D. Medical coding in clinical trials. Perspect Clin Res. 2010;1(1):29–32.

2. Lu Z. Technical challenges in designing post-marketing eCRFs to address clinical safety and pharmacovigilance needs. Contemp Clin Trials. 2010;31(1):108–18.

3. Nair GJ. Ensuring quality in the coding process: a key differentiator for the accurate interpretation of safety data. Perspect Clin Res. 2013;4(3):181–5.

4. FDA. FDA Data Standards Catalog v5.2 (12-20-2018). In. https://www.fda.gov/industry/fda-resources-data-standards/study-data-standards-resources: FDA.

5. PMDA. Notification on Practical Operations of Electronic Study Data Submissions In: Bureau PaFS, ed. https://www.pmda.go.jp/english/review-services/reviews/0002.html: PMDA; 2019.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3